• Merck & Co., Inc. (MRK) Gambles on Startups for R&D More...
• Teva Pharmaceutical Industries Limited (TEVA) Facility In Phildelphia Now Seems Uncertain, 400 New Jobs May be Put on Hold More...
• BioInvent (BOVNF), ThromboGenics NV (TBGNF) Plunges as Development of Anticoagulent is Dropped More...
• Merck & Co., Inc. (MRK) Says New Insomnia Drug Was Effective in a Year-Long Test More...
• BioSpecifics Technologies Corporation (BSTC) Reports Positive Phase III Data From XIAFLEX Clinical Trials More...
• Should the Johnson & Johnson (JNJ) Zytiga Trial Have Ended Early? More...
• Merck & Co., Inc. (MRK) Finds Its Phase II Candidates for Sale on the Internet More...
• Merck & Co., Inc. (MRK) Sleep Drug Effective in Year-long Test More...
• Should the Johnson & Johnson (JNJ) Zytiga Trial Have Ended Early? More...
• BioSpecifics Technologies Corporation (BSTC) Reports Positive Phase III Data From XIAFLEX Clinical Trials More...
• Abbott Laboratories (ABT) Announces Initiation of Phase 3 Study of Elagolix in Patients with Endometriosis More...
• Addex Therapeutics (ADXN.SW) Partner to Initiate Phase 2 Clinical Trial of ADX71149 for the Treatment of Major Depressive Disorder With Anxiety Symptoms More...
• BioInvent (BOVNF), ThromboGenics NV (TBGNF) Plunges as Development of Anticoagulent is Dropped More...
• Lupin Pharmaceuticals, Inc. Receives FDA Approval for SUPRAX® (Cefixime) Capsules, 400 Mg More...
• IGI Laboratories, Inc. Announces the Submission of Sixth ANDA More...
• pSivida Corp (PSDV) Announces Portugal Grants ILUVIEN® Marketing Authorization for the Treatment of Chronic Diabetic Macular Edema More...
• VIVUS, Inc. (VVUS) Provides Update on Timing of European Decision for Qnexa® More...
• Three Coffees a Day Keeps Alzheimer's Disease Away, University of South Florida and University of Miami Study More...
• Soy Doesn't Boost Brainpower in Older Women, Stanford University School of Medicine Study More...
• Iron Pills May Help Women Beat Fatigue, University of Lausanne Study More...
• "Good Fat" Activated by Cold, Not Ephedrine, Joslin Diabetes Center Study More...
• Brain Response to Guilt May Be Key to Depression, University of ManchesterStudy More...
• BioLineRx Ltd. Announces Receipt of Two Notices of Allowance from USPTOfor Patents Covering BL-1021, an Orally Available New Chemical Entity for Treatment of Neuropathic Pain More...
• Kadmon Pharmaceuticals Launches 600 mg/day Ribasphere® RibaPak® to Provide Added Dosing Control for Triple Therapy Treatment of Chronic Hepatitis C More...
0 comments